The global pediatric ENT market size is anticipated to reach at USD 10.17 billion by 2030 and is projected to grow at a CAGR of 5.02% from 2024 to 2030, according to a new report by Grand View Research, Inc. There is an increasing emphasis on early diagnosis and treatment of ENT disorders in children. This awareness drives parents and healthcare providers to seek out advanced diagnostic devices and treatment options, further propelling market growth.
Recent advancements in cochlear implants for pediatric patients include the introduction of the Cochlear Nucleus 8 Sound Processor, which received FDA approval for use in children aged 9 to 24 months in November 2022. This processor is noteworthy for being the most powerful and smallest Behind-The-Ear (BTE) cochlear implant sound processor available, and it has Bluetooth LE Audio technology, allowing direct audio connectivity to consumer electronics. This innovation aims to enhance the listening experience for children by automatically adjusting to environmental changes and reducing background noise during conversations.
Themarket is experiencing growth, significantly influenced by recent FDA approvals and initiatives aimed at enhancing the availability of medical devices specifically designed for children. In December 2023, Acclarent became the first and only company to receive FDA clearance for a new treatment option for children requiring repeat ear tubes.
Request a free sample copy or view report summary: Pediatric ENT Market Report
Pediatric ENT Market Report Highlights
The diagnostic ENT devices segment led the market with the largest revenue share of 57.15% in 2023. The hearing implant segment is expected to grow at the fastest CAGR during the forecast period. This can be attributed to the increasing preference for cochlear implants as non-invasive methods.
North America dominated the market with the revenue share of 34.14% in 2023, owing to improving digital health infrastructure, rising healthcare expenditure, and presence of major ENT device manufacturers.
The FDA is actively promoting the development and approval of pediatric medical devices, recognizing the unique needs of children. This includes increasing the number of devices labeled for pediatric use and involving pediatric experts in advisory panels to ensure safety and efficacy for younger populations.
In August 2023, Phonak launched new advancements for its Lumity platform to better cater to individuals with untreated hearing loss in one ear and teens, children, and adults those with severe-to-severe hearing loss.
Pediatric ENT Market Segmentation
Grand View Research has segmented the global pediatric ENT market report based on product, and region.
Pediatric ENT Product Outlook (Revenue, USD Million, 2018 - 2030)
Diagnostic ENT Devices
Surgical ENT Devices
Hearing Aids
Hearing Implants
Nasal Splints
Pediatric ENT Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Mexico
Europe
UK
Germany
France
Italy
Spain
Sweden
Denmark
Norway
Asia Pacific
Japan
China
India
Australia
Thailand
South Korea
Latin America
Brazil
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players in the Pediatric ENT Market
Medtronic
Karl Storz
Stryker Corporation
Smith & Nephew plc
Olympus Corporation
Cochlear Ltd.
Demant A/S
GN Store Nord A/S
Ambu A/S
Pentax Medical
FUJIFILM Holdings
Acclarent
Preceptis Medical
Explore Horizon, the world’s most expansive market research database
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
